/Companies

DSIpharma

Wilmington, US · Founded 2025 · Delaware corporation

Find your way into DSIpharma

Sign up to see every warm intro you have to DSIpharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DSIpharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

KA
Kysha Ayana Pierre-LouisNamed on SEC filing
MR
Mark RidallNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$951.3K disclosed across 1 round · 2025

▶$951.3KraisedOct 2026 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark RidallExecutive Officer, Director
  • Kysha Ayana Pierre-LouisExecutive Officer, Director
Offering amount
$3M
Amount sold
$951.3K
Proceeds to insiders
$90K
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has DSIpharma raised?
DSIpharma has disclosed $951.3K raised across 1 round.
Where is DSIpharma headquartered?
DSIpharma is headquartered in Wilmington, US.